Unlikely to cause harm — often a labeling or packaging issue.
Out of Specification result observed in content uniformity testing
| Brand name | DOFETILIDE |
| Generic name | DOFETILIDE |
| Active ingredient(s) | DOFETILIDE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 |
| NDC | 47335-063-86 |
| Full product label | Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide in the USA |
| Quantity | 360 60-count bottles |
| Recall initiated | 2023-07-18 |
| Report date | 2023-08-16 |
| Recall completed | 2024-02-26 |
| Recall number | D-1082-2023 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗